These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32823452)

  • 1. Tofacitinib in recalcitrant scleritis: First case report from India.
    Pyare R; Kaushik V; Dutta Majumder P; Biswas J
    Indian J Ophthalmol; 2020 Sep; 68(9):1988-1990. PubMed ID: 32823452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anterior Scleritis Manifesting After Coronavirus Disease 2019: A Report of Two Cases.
    Feizi S; Meshksar A; Naderi A; Esfandiari H
    Cornea; 2021 Sep; 40(9):1204-1206. PubMed ID: 34351874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Branch retinal vein occlusion in a case of recalcitrant diffuse anterior scleritis treated with tofacitinib.
    Manoharan A; Atmakur H; Dutta Majumder P; Biswas J
    J Ophthalmic Inflamm Infect; 2023 Sep; 13(1):45. PubMed ID: 37755540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil for the treatment of scleritis.
    Sen HN; Suhler EB; Al-Khatib SQ; Djalilian AR; Nussenblatt RB; Buggage RR
    Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recalcitrant infective scleritis masquerading an autoimmune necrotising scleritis: a primary presentation of biopsy-proven granulomatosis with polyangiitis.
    Agarwal R; Tripathi M; Kashyap S; Sharma S
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33472807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of refractory cutaneous dermatomyositis: potential role of Janus kinase inhibition with tofacitinib.
    Moghadam-Kia S; Charlton D; Aggarwal R; Oddis CV
    Rheumatology (Oxford); 2019 Jun; 58(6):1011-1015. PubMed ID: 30608616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of necrotizing scleritis resulting from Pseudomonas aeruginosa.
    Moreno Honrado M; del Campo Z; Buil JA
    Cornea; 2009 Oct; 28(9):1065-6. PubMed ID: 19724201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Profile of Patients with Necrotizing Scleritis in a Tertiary Eye Care Center in Southern India.
    Dutta Majumder P; Ghose A; Chidambaram M; Ganesh SK; Biswas J
    Ocul Immunol Inflamm; 2018; 26(3):412-416. PubMed ID: 27762661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of idiopathic necrotizing scleritis with secondary glaucoma treated successfully with golimumab and Ahmed valve implantation.
    Dutta Majumder P; ; David RL; Kaushik V
    Indian J Ophthalmol; 2019 Aug; 67(8):1360-1362. PubMed ID: 31332143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tofacitinib for the treatment of ulcerative colitis.
    Izzo R; Bevivino G; Monteleone G
    Expert Opin Investig Drugs; 2016 Aug; 25(8):991-7. PubMed ID: 27177233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of Tofacitinib in the treatment of inflammatory bowel disease.
    Nasonov EL; Abdulganieva DI; Fairushina IF
    Ter Arkh; 2019 Mar; 91(2):101-108. PubMed ID: 31094180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical profile of patients with anterior nodular scleritis in India.
    Patnaik G; Sudharshan S; George AE; Ganesh SK; Biswas J; Dutta Majumder P
    Indian J Ophthalmol; 2020 Sep; 68(9):1925-1928. PubMed ID: 32823416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tofacitinib in Scleritis: A Case Series.
    Pyare R; Dutta Majumder P; Shah M; Kaushik V; Agarwal M; Biswas J
    Ocul Immunol Inflamm; 2022 Sep; ():1-7. PubMed ID: 36126052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis.
    Boyle DL; Soma K; Hodge J; Kavanaugh A; Mandel D; Mease P; Shurmur R; Singhal AK; Wei N; Rosengren S; Kaplan I; Krishnaswami S; Luo Z; Bradley J; Firestein GS
    Ann Rheum Dis; 2015 Jun; 74(6):1311-6. PubMed ID: 25398374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual outcome, treatment results, and prognostic factors in patients with scleritis.
    Wieringa WG; Wieringa JE; ten Dam-van Loon NH; Los LI
    Ophthalmology; 2013 Feb; 120(2):379-86. PubMed ID: 23177360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tofacitinib for the treatment of moderate-to-severe psoriasis.
    Chiricozzi A; Faleri S; Saraceno R; Bianchi L; Buonomo O; Chimenti S; Chimenti MS
    Expert Rev Clin Immunol; 2015 Apr; 11(4):443-55. PubMed ID: 25666451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement.
    Orsolini G; Bertoldi I; Rossini M
    Clin Rheumatol; 2020 Mar; 39(3):727-736. PubMed ID: 31970549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tofacitinib Treatment of Refractory Systemic Juvenile Idiopathic Arthritis.
    Huang Z; Lee PY; Yao X; Zheng S; Li T
    Pediatrics; 2019 May; 143(5):. PubMed ID: 30948682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necrotizing Scleritis After Cosmetic Conjunctivectomy With Mitomycin C.
    Ji YW; Park SY; Jung JW; Choi S; Alotaibi MH; Stulting RD; Hwang DG; Seo KY
    Am J Ophthalmol; 2018 Oct; 194():72-81. PubMed ID: 30053476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tofacitinib for treatment of rheumatoid arthritis.
    Rakieh C; Conaghan PG
    Adv Ther; 2013 Aug; 30(8):713-26. PubMed ID: 23943546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.